Current strategies for the prevention and management of central line-associated bloodstream infections
暂无分享,去创建一个
J. Marschall | S. Liang | Jonas Marschall | Zhuolin Han | Stephen Y Liang | Zhuolin Han | Stephen Y. Liang | Jonas Marschall
[1] H. Danawi,et al. Management of central venous catheters in patients with cancer and candidemia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] I. Raad,et al. Management of Bacillus Bacteremia: The Need for Catheter Removal , 2009, Medicine.
[3] I. Gadea,et al. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia , 2002, Journal of internal medicine.
[4] L. Szczech,et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Vance G Fowler,et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. , 2006, The New England journal of medicine.
[6] Peter J Pronovost,et al. Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.
[7] P. Lebecque,et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] L. Mermel,et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.
[9] J. Sasadeusz,et al. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies. , 2008, The Journal of infection.
[10] K. Chan,et al. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. , 1993, Journal of the American College of Cardiology.
[11] P. Martín-Dávila,et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. , 2006, The Journal of antimicrobial chemotherapy.
[12] M. Samore,et al. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. , 1995, Archives of internal medicine.
[13] P. Diggle,et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] Á. Soriano,et al. Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms , 2010, Antimicrobial Agents and Chemotherapy.
[15] Y. Harihara,et al. Maximal Sterile Barrier Precautions Do Not Reduce Catheter-Related Bloodstream Infections in General Surgery Units: A Multi-Institutional Randomized Controlled Trial , 2010, Annals of surgery.
[16] D. Maki,et al. A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.
[17] M. Jadoul,et al. Catheter-related blood stream infections (CRBSI): a European view. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] D. Maki,et al. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. , 2007, The Lancet. Infectious diseases.
[19] L. Wise,et al. Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. , 2008, Surgery.
[20] M. Falagas,et al. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. , 2007, European journal of pharmacology.
[21] C. Carpenter,et al. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Linda J Stang,et al. Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. , 2005, The Journal of antimicrobial chemotherapy.
[23] F Golliot,et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. , 2001, JAMA.
[24] F. Martínez Sagasti,et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. , 2010, JAMA.
[25] N. Sucu,et al. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. , 2007, JPEN. Journal of parenteral and enteral nutrition.
[26] L. Ginzton,et al. Transesophageal echocardiography in diagnosis of infective endocarditis. , 1994, Chest.
[27] J. L. Iribarren,et al. Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site* , 2007, Critical care medicine.
[28] M. Rupp,et al. Ethanol Lock Technique: Review of the Literature , 2009, Infection Control & Hospital Epidemiology.
[29] C. Schorr. Chlorhexidine-Impregnated Sponges and Less Frequent Dressing Changes for Prevention of Catheter-Related Infections in Critically Ill Adults: A Randomized Controlled Trial , 2010 .
[30] D. Snydman,et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. , 1995, Archives of internal medicine.
[31] L. Elting,et al. Septicemia Due to Xanthomonas Species and Non‐Aeruginosa Pseudomonas Species: Increasing Incidence of Catheter‐Related Infections , 1990, Medicine.
[32] John M. Starmer,et al. Systems initiatives reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. , 2010, The Journal of trauma.
[33] Stephen J. Wilson,et al. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention. , 2006, American journal of infection control.
[34] M. Taylor,et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. , 2002, Kidney international.
[35] J. Sobel,et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] D. Pittet,et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care , 2000, The Lancet.
[37] J. L. Del Pozo. Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. , 2009, The International journal of artificial organs.
[38] M. Wagener,et al. Risk of Infection Due to Central Venous Catheters: Effect of Site of Placement and Catheter Type , 1998, Infection Control & Hospital Epidemiology.
[39] J. Timsit,et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. , 2009, JAMA.
[40] C. Brun-Buisson,et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures , 1999, The Lancet.
[41] H. Sax,et al. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected. , 2009, The Journal of hospital infection.
[42] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] B. Almirante,et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. , 2006, The Journal of antimicrobial chemotherapy.
[44] D. Maki,et al. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. , 2005, Chest.
[45] M. Ghannoum,et al. Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.
[46] G. Bodey,et al. Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions During Insertion , 1994, Infection Control & Hospital Epidemiology.
[47] J. Leiva,et al. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. , 2009, Diagnostic microbiology and infectious disease.
[48] V. Gill,et al. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population , 1987, Journal of clinical microbiology.
[49] M. Wilcox,et al. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. , 2002, The Journal of antimicrobial chemotherapy.
[50] E. Wong,et al. A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections , 2006, Infection Control & Hospital Epidemiology.
[51] G. Bodey,et al. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy , 1994, Antimicrobial Agents and Chemotherapy.
[52] E. Anaissie,et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. , 1993, The Journal of infectious diseases.
[53] Leonard Leibovici,et al. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.
[54] M. Wallen,et al. Optimal timing for intravenous administration set replacement. , 2005, Anesthesia and Analgesia.
[55] J. Jollis,et al. Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia , 1999, Annals of Internal Medicine.
[56] L. Lorente,et al. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters , 2005, Critical care.
[57] M. Allon. Dialysis catheter-related bacteremia: treatment and prophylaxis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] J. Fine,et al. Meta-Analysis: Methods for Diagnosing Intravascular DeviceRelated Bloodstream Infection , 2005, Annals of Internal Medicine.
[59] J. Gavaldà,et al. Management of Catheter-Related Staphylococcus aureus Bacteremia: When May Sonographic Study Be Unnecessary? , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[60] S. Amyes,et al. OXA (beta)-lactamases in Acinetobacter: the story so far. , 2006, The Journal of antimicrobial chemotherapy.
[61] Dan M. Kluger,et al. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.
[62] J. Leiva,et al. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. , 2009, International journal of antimicrobial agents.
[63] L. Peterson,et al. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. , 1994, Archives of internal medicine.
[64] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.
[65] B. Souweine,et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. , 2008, JAMA.
[66] K. Ho,et al. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. , 2006, The Journal of antimicrobial chemotherapy.
[67] S. Hugonnet,et al. Nosocomial Bacteremia Clinical Significance of a Single Blood Culture Positive for Coagulase-Negative Staphylococci , 2005, Infection Control & Hospital Epidemiology.
[68] C. Fairley,et al. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. , 2002, The Journal of infection.
[69] T. Perl,et al. Chlorhexidine: expanding the armamentarium for infection control and prevention. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] M. Allon. Treatment guidelines for dialysis catheter-related bacteremia: an update. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[71] J. Tarrand,et al. Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse , 2004, Infection Control & Hospital Epidemiology.
[72] D. Herr,et al. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.
[74] Stephen E. Muething,et al. Decreasing PICU Catheter-Associated Bloodstream Infections: NACHRI's Quality Transformation Efforts , 2010, Pediatrics.
[75] A. Wald,et al. Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters , 2001, Bone Marrow Transplantation.
[76] Didier Pittet,et al. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. , 2002, American journal of infection control.
[77] S. Hugonnet,et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.
[78] Sanjay Saint,et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. , 2002, Annals of internal medicine.
[79] A. Sturm,et al. Treatment failure due to extended spectrum beta-lactamase. , 1996, The Journal of antimicrobial chemotherapy.
[80] D. Shapiro,et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis , 1997, Journal of clinical microbiology.
[81] B. Walder,et al. Complications of central venous catheters: Internal jugular versus subclavian access—A systematic review , 2002, Critical care medicine.
[82] T. Walley,et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review* , 2009, Critical care medicine.
[83] D. Kovacevich,et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[84] A. Wilmer,et al. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial , 2004, Intensive Care Medicine.
[85] S. Saint,et al. Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[86] K. Papadakis,et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[87] W. Onland,et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. , 2006, Archives of pediatrics & adolescent medicine.
[88] I. Raad,et al. The Crucial Role of Catheters in Micrococcal Bloodstream Infections in Cancer Patients , 2009, Infection Control & Hospital Epidemiology.
[89] K. Farrington,et al. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. , 2003, Journal of Antimicrobial Chemotherapy.
[90] C. Edmiston,et al. Treatment of Hickman Catheter Sepsis Using Antibiotic Lock Technique , 1995, Infection Control & Hospital Epidemiology.
[91] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[92] S. Saint,et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[93] P. Pronovost,et al. An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.
[94] P. Patel,et al. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[95] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[96] L. Leibovici,et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.
[97] H. Goossens,et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[98] C. Alvarado,et al. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1991, The Lancet.
[99] C. Woods,et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] Peter J Pronovost,et al. Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections , 2010, Critical care medicine.
[101] T. Greene,et al. Effect of change in vascular access on patient mortality in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[102] Nasia Safdar,et al. Educational interventions for prevention of healthcare-associated infection: A systematic review , 2007, Critical care medicine.
[103] J. Barsuk,et al. Use of simulation-based education to reduce catheter-related bloodstream infections. , 2009, Archives of internal medicine.
[104] B. Allegranzi,et al. Role of hand hygiene in healthcare-associated infection prevention. , 2009, The Journal of hospital infection.
[105] R. Zbinden,et al. Significance of Staphylococcus lugdunensis Bacteremia: Report of 28 Cases and Review of the Literature , 2008, Infection.
[106] Jeanne E. Zack,et al. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center* , 2003, Critical care medicine.
[107] Joshua A. Doherty,et al. Automated Surveillance for Central Line–Associated Bloodstream Infection in Intensive Care Units , 2008, Infection Control & Hospital Epidemiology.
[108] C. Salgado,et al. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[109] E. Anaissie,et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[110] R. Salomão,et al. Risk Factors for Death in Patients With Candidemia , 1998, Infection Control & Hospital Epidemiology.
[111] J. D. Pozo,et al. Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. , 2009 .
[112] M. Allon,et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[113] W. Peetermans,et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. , 2005, The Journal of antimicrobial chemotherapy.
[114] D. K. Benjamin,et al. Bacteremia, central catheters, and neonates: when to pull the line. , 2001, Pediatrics.
[115] H. Nemoto,et al. To reduce catheter-related bloodstream infections: Is the subclavian route better than the jugular route for central venous catheterization? , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[116] Reduction in central line-associated bloodstream infections among patients in intensive care units--Pennsylvania, April 2001-March 2005. , 2005, MMWR. Morbidity and mortality weekly report.
[117] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[118] Marin H Kollef,et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. , 2004, Chest.
[119] E. Eviatar,et al. Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. , 2007, Kidney international.
[120] Walter Zingg,et al. Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections* , 2009, Critical care medicine.
[121] A. Dubrow,et al. Adjunctive Antibiotic/Anticoagulant Lock Therapy in the Treatment of Bacteremia Associated with the Use of a Subcutaneously Implanted Hemodialysis Access Device , 2000, ASAIO journal.
[122] P. Ganly,et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. , 2008, The Journal of antimicrobial chemotherapy.
[123] Didier Pittet,et al. Guideline for Hand Hygiene in Health-Care Settings Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC / SHEA / APIC / IDSA Hand Hygiene Task Force , 2002 .
[124] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[125] H. Goossens,et al. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). , 2005, Diagnostic microbiology and infectious disease.
[126] Jerome J. Schentag,et al. Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2007, Antimicrobial Agents and Chemotherapy.
[127] L. Rasero,et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). , 2000, Haematologica.
[128] C. Libertin,et al. Endocarditis Complicating Central Venous Catheter Bloodstream Infections: A Unique Form of Health Care Associated Endocarditis , 2009, Clinical cardiology.
[129] S. Boschi,et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). , 2000, Haematologica.
[130] Hugo Sax,et al. Evidence-based model for hand transmission during patient care and the role of improved practices. , 2006, The Lancet. Infectious diseases.
[131] B. Debaene,et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. , 2007, Archives of internal medicine.
[132] S. Amyes,et al. OXA β-lactamases in Acinetobacter: the story so far , 2006 .
[133] Peter J Pronovost,et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study , 2010, BMJ : British Medical Journal.
[134] M. Falagas,et al. Treatment of Acinetobacter infections , 2010 .
[135] L. Rubin,et al. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters , 1993, Journal of clinical microbiology.
[136] P. Gastmeier,et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial , 2009, Annals of Hematology.
[137] M. Jadoul,et al. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[138] Á. Soriano,et al. Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[139] I. Raad,et al. Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered? , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[140] Deborah L. Higgins,et al. Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.
[141] E. Anaissie,et al. Predictors of adverse outcome in cancer patients with candidemia. , 1998, The American journal of medicine.
[142] W. Bilker,et al. Reemergence of gram-negative health care-associated bloodstream infections. , 2006, Archives of internal medicine.
[143] R. Arbeit,et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[144] Robert Sherertz,et al. Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection , 2000, Annals of Internal Medicine.
[145] H. Kniemeyer,et al. Surgical treatment of septic deep venous thrombosis. , 1995, Surgery.
[146] N. Duncan,et al. Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[147] Jeanne E. Zack,et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit , 2002, Critical care medicine.
[148] Nasia Safdar,et al. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. , 2005, American journal of infection control.
[149] J. Edgeworth. Intravascular catheter infections. , 2009, The Journal of hospital infection.